Table 2.
Comparison of immune function indexes between the two groups ().
Groups | n | CD3+ (%) | CD+4 (%) | CD8+ (%) | CD4+/CD8+ |
---|---|---|---|---|---|
Observation group (n = 30) | Before treatment | 57.94 ± 6.22 | 29.32 ± 3.41 | 26.69 ± 2.53 | 1.05 ± 0.15 |
After treatment | 68.23 ± 7.72 | 41.48 ± 4.03 | 27.20 ± 2.37 | 1.57 ± 0.26 | |
t | 5.685 | 12.627 | 0.805 | 9.386 | |
P | ≤0.001 | ≤0.001 | 0.424 | ≤0.001 | |
Control group (n = 30) | Before treatment | 57.03 ± 6.95 | 29.50 ± 3.63 | 26.32 ± 2.49 | 1.06 ± 0.16 |
After treatment | 62.49 ± 5.56 | 35.28 ± 3.61 | 26.45 ± 2.20 | 1.34 ± 0.10 | |
t | 3.357 | 6.1921 | 0.214 | 8.707 | |
p | 0.001 | ≤0.001 | 0.831 | ≤0.001 | |
t1 | 0.534 | 0.209 | 0.570 | 0.255 | |
P | 0.595 | 0.836 | 0.571 | 0.800 | |
t2 | 3.305 | 6.284 | 1.270 | 4.296 | |
P | 0.002 | ≤0.001 | 0.209 | ≤0.001 |
Note: t1 represents the comparison between the two groups before treatment, and t2 represents the comparison between the two groups after treatment.